FindMyKOL
Clinical trialNCT03853772Enrolling, by, invitationObservational

The Johns Hopkins Heartburn Center Registry

NCT03853772 is an observational study sponsored by Johns Hopkins University. As of 21 Nov 2026, it is enrolling by invitation only. It studies Barrett Esophagus, Esophagitis and 2 more conditions. The registry lists an enrollment of 2,000 participants at 9 sites in 1 country. The registry lists a start date of 27 Apr 2019 and a primary completion date of 31 Dec 2027.

SponsorJohns Hopkins University →Enrollment2,000Barrett EsophagusEsophagitisGastroesophageal Reflux DiseaseLaryngopharyngeal Reflux
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT03853772
FieldValue
Registry IDNCT03853772
StatusEnrolling by invitation
Study typeObservational study
Lead sponsorJohns Hopkins University
Enrollment2,000
Registered sites9
Countries1
ConditionsBarrett Esophagus, Esophagitis, Gastroesophageal Reflux Disease and Laryngopharyngeal Reflux
Start27 Apr 2019
Primary completion31 Dec 2027
Study completion31 Dec 2028
Last update posted26 Aug 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A multi-center, multi-year registry of patients with gastroesophageal reflux disease (GERD) undergoing diagnostic evaluation and/or treatment of GERD and associated diseases and complications.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

California, United States1 site
  • Uci-Irvine

    Orange

Maryland, United States1 site
  • Johns Hopkins Hospital

    Baltimore

Minnesota, United States1 site
  • Mayo Clinic

    Rochester

Nevada, United States1 site
  • Unrmed-University of Nevada, Reno

    Reno

New York, United States1 site
  • Weill Cornell

    New York

Pennsylvania, United States1 site
  • Geisinger

    Danville

Texas, United States2 sites
  • the Matagorda Regional Medical Group

    Bay City

  • Ut Health

    Houston

Wisconsin, United States1 site
  • Fox Valley Surgical Associates

    Appleton

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesota: 1 siteMN1Wisconsin: 1 siteWI1MichiganMINew York: 1 siteNY1MassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvania: 1 sitePA1New JerseyNJConnecticutCTCalifornia: 1 siteCA1Nevada: 1 siteNV1WyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMaryland: 1 siteMD1DelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexas: 2 sitesTX2FloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT03853772

Each answer restates registry values shown on this page.

What is NCT03853772?

NCT03853772 is an observational study sponsored by Johns Hopkins University. It studies Barrett Esophagus, Esophagitis and 2 more conditions.

Is NCT03853772 recruiting?

As of 21 Nov 2026, it is enrolling by invitation only.

Who leads NCT03853772?

The registry names Marcia Canto, MD (principal investigator, Johns Hopkins University) as the overall official.

Where does NCT03853772 run?

The registry lists 9 sites in 1 country. Every site with a stated country is in one country: United States.

When is NCT03853772 expected to complete?

The registry lists a primary completion date of 31 Dec 2027 and a study completion date of 31 Dec 2028. The sponsor last updated the record on 26 Aug 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.